MedTrace Logo

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

NCT02066961 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1533

Last updated 2019-12-20

No results posted yet for this study

Summary

The purpose of this study is to describe patterns in disease management and to describe clinical outcomes, as well as to identify factors influencing physician treatment decisions including reason(s) for treatment choices and trigger(s) for treatment changes and to document healthcare resource utilization used to manage treatment-related complications.

Conditions

Sponsors & Collaborators

  • Astellas Pharma Global Development, Inc.

    lead INDUSTRY

Principal Investigators

  • Senior Medical Director · Astellas Pharma Global Development, Inc.

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2019-11-14
Completion
2019-11-14

Countries

  • Algeria
  • Argentina
  • Australia
  • Austria
  • Brazil
  • Canada
  • Colombia
  • Egypt
  • France
  • Germany
  • Indonesia
  • Israel
  • Italy
  • Lebanon
  • Mexico
  • Netherlands
  • New Zealand
  • Oman
  • Peru
  • Philippines
  • Saudi Arabia
  • Singapore
  • South Korea
  • Spain
  • Taiwan
  • Thailand
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02066961 on ClinicalTrials.gov